The Buzz Surrounding Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO)

Jan. 28, 2019 - Cannabix Technologies Completes Breath Collection Unit and Provides Update

Cannabix Technologies Inc. (CSE: BLO) (OTC: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, reported that it has received an initial version of its portable handheld device that will provide for easy collection of breath samples at the point of care. In collaboration with Company scientists, MistyWest Engineering of Vancouver was engaged to develop a breath collection unit (“BCU”) in late November, that would interface directly with the innovative FAIMS (field asymmetric waveform ion mobility spectrometry) based instrument for the detection of THC in human breath that Cannabix is developing. The BCU is a proprietary device that will make it easier to collect key physiologic breath sample data under different environmental conditions to determine the effects of such parameters on a ∆9-tetrahydrocannabinol (“THC”) breath sample.  BCU components were machined and assembled over the course of December and January and MistyWest has delivered an initial version of the BCU. Images of the Cannabix BCU can be seen at the Company’s website at cannabixtechnologies.com

Cannabix Technologies Inc. Breath Collection Unit

Cannabix will use the new BCU for the collection of multiple samples, from multiple users under a variety of conditions, in an efficient manner. The BCU is lightweight, runs on a conventional battery and includes a self-contained specialized breath sample container that integrates directly with the Company’s FAIMS detection device for analysis. The BCU has been designed to collect numerous samples required for pilot and research testing and be easy to administer by untrained personnel.

The BCU real time data display wirelessly connects to an android device for live data streaming and this data can be sent to the cloud for further analysis and storage. Currently the BCU will collect key real-time parameters of breath flow rate, total volume, relative humidity measurements, as well as carbon dioxide levels, and temperature – these measurements and others, will help Cannabix, regulators and industry scientists determine key physiologic parameters needed for standardizing a breath sample for FAIMS THC content and its decay metrics. There is currently scant information related to these critical physiologic data points available for human breath in THC smokers.

Cannabix has been building upon its promising characterization results from 2018 and with additional FAIMS cells to improve resolving power and establish repeatable results in multiple devices. Thus far testing has demonstrated the ability to isolate Δ9-tetrahydrocannabinol (“THC”) and suppress background substrates substantially. FAIMS works as an “ion blocking” technology, essentially blocking unwanted ions/analytes and allowing specified ions to pass through for detection. The characterization work has been conducted using a bench version of the FAIMS device. Cannabix scientists have been actively tuning the FAIMS device coupled to real time switchable mass spectrometry to detect key molecules and their complex pathways in the body to enable the identification of recency of use.

Nov. 15, 2018 - Cannabix Technologies Engages MistyWest - Provides Development Update on Marijuana Breathalyzer

Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, reported that it has engaged a leading B.C. based engineering and design firm for the development of a handheld breath collection device for its marijuana breathalyzer unit. MistyWest Engineering of Vancouver has begun work on a portable handheld device that will provide for easy collection of breath samples at the point of care.

MistyWest is a highly regarded engineering and design firm that has worked on several high profile and innovative product development projects in North America –demonstrating the ability to complete projects rapidly. Cannabix will use the new handheld unit for the collection of multiple samples from many users under a variety of conditions, quickly. The new breath collection unit (“BCU”) will provide key physiologic breath sample data under different environmental conditions to determine the effects such parameters on a ∆9-tetrahydrocannabinol (“THC”) breath sample. The device will be lightweight and include advanced display capabilities as well as temperature, pressure and relative humidity measurement capabilities. The BCU will be designed to collect numerous samples required for pilot and research testing and be easy to administer by untrained personnel. Furthermore, the BCU will allow scientists to store samples and determine the effects of decay time on the sample which is an important parameter in the evidentiary process. It is estimated that the new handheld unit will be ready by the end of this year. This BCU will interface directly with the innovative FAIMS (field asymmetric waveform ion mobility spectrometry) based instrument for the detection of THC in human breath that Cannabix is developing.

Dr. Raj Attariwala stated, “We are pleased to be working with a local firm MistyWest on the development of this breath collection unit as it will aid in our ability to collect multiple breath samples under various conditions to enhance our capacity for sample collection, storage and handling. The engineers at MistyWest have a lot of experience with human factor design and creating these kinds of devices efficiently. This will integrate with our added capacity for gas analysis using our new state of the art equipment at our Florida facility.” 

The Company also reports that it has recently expanded its lab space in Gainesville, Florida and acquired an additional Thermo Scientific GC mass spectrometer that is designed to analyze breath samples by using the gold standard for gas analysis by enabling thermal desorption from sorbent tubes. In addition, Cannabix has added additional electrical engineering staff in Vancouver.

Oct. 16, 2018 - Cannabix Technologies Comments on Legalization of Marijuana in Canada, Impaired Driving and Workplace Safety

 Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace provides the following statement related to the legalization of marijuana for recreational use across Canada: “The introduction of legalized marijuana use in Canada is a watershed moment as it relates to public safety on our roads and workplaces. Cannabix applauds the significant efforts that are underway by the Government of Canada and others to increase public awareness of the dangers of drugged driving on our roadways and the acute problems of being under the influence of drugs in the workplace. A recent survey by the Angus Reid Institute (dated September 25, 2018) finds a majority of Canadians lack confidence in the ability of their community police to assess and punish those driving under the influence of marijuana. Furthermore, according to MADD Canada, drugs are present in fatal crashes nearly twice as often as alcohol and that Canada’s existing system does a very poor job of detecting drivers under the influence of drugs (news release May 29, 2018). The Human Resources Professionals Association in January 2018, conducted a survey in Ontario and found that 71 per cent of its members do not feel prepared for legalization, with almost 48 per cent citing concerns about ensuring a safe workplace. As the issue of drugged driving and influence of drugs in the workplace becomes increasingly acute, Cannabix is using its technology, research and development (R&D) and scientific experience to develop effective tools to aid law enforcement and help governments and the public transition to marijuana legalization in various jurisdictions. Cannabix Technologies has been on the forefront in R&D to create an accurate breath test for ∆9-tetrahydrocannabinol - the psychoactive component of marijuana that causes impairment. We believe that establishing point-of-care breath testing technology for cannabis is the future for law enforcement and workplace testing, as it is non-invasive, will be easy to use, and will look to provide superior sensitivity to help better determine impairment.  Cannabix is a well funded Canadian company that is rapidly developing marijuana breathalyzer technology.

Cannabix has been building upon its promising characterization results from August and with a secondary bench version device to establish repeatable results in multiple devices.  Thus far testing has demonstrated the ability to isolate ∆9-tetrahydrocannabinol (“THC”) and suppress background substrates and scientists are continuously working to improve resolving power. Cannabix is developing an innovative FAIMS (field asymmetric waveform ion mobility spectrometry) based instrument for the detection of THC.

FAIMS works as an “ion blocking” technology, essentially blocking unwanted ions/analytes and allowing specified ions to pass through for detection. The characterization work has been conducted using a bench version of the FAIMS device. Cannabix scientists have been actively tuning the FAIMS device coupled to real time switchable mass spectrometry to detect key molecules and their complex pathways in the body to enable the identification of recency of use.  

The Company also reports that it has short listed 2 potential medical device development companies in order to develop the next version of the device as well as create multiple devices, that would be used for pilot testing.

Aug 27, 2018 - Cannabix Technologies Engages MistyWest - Provides Development Update on Marijuana Breathalyzer

Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that characterization work has demonstrated the ability to isolate ∆9-tetrahydrocannabinol (“THC”) and suppress background substrates effectively. Cannabix is developing an innovative FAIMS (field asymmetric waveform ion mobility spectrometry) based instrument for the detection of THC. Using the gold standard of mass spectrometry in tandem with the Cannabix FAIMS prototype device, Graph A and B below show suppression of background matrix allowing the THC peak to be easily recognized.  This demonstrates the capability of the FAIMS device to isolate and detect THC from complex background matrix. The characterization work has been conducted using a bench version of the FAIMS device. Cannabix scientists have been actively tuning the FAIMS device coupled to real time switchable mass spectrometry to detect key molecules and their complex pathways in the body to enable the identification of recency of use. 

The Company also reports that it has commenced identification of medical device manufacturers in order to implement human factor design (single or dual stage design), verification testing, and develop manufacturing documentation for standardization requirements, as well as create multiple devices for pilot testing.

20 Comments
  1. Melvin Rosario 4 months ago
    Reply

    this is definitely required as legalization is imminent in the states.

    • Dillon Harper 4 months ago
      Reply

      Even having cannabis in a bag/paraphernalia in the car is not an indication of the drivers impairment anymore than a 6 pack and a koozie is. Not to say they can’t pull you over for reckless driving, but that’s different from a DUI.

      • Eleanor Mills 4 months ago
        Reply

        is it possible to use this technology to test for ailments?

    • John Liu 4 months ago
      Reply

      the market for this will grow from here as law enforcement will continue to need it as more states legalize recreational and medical cannabis

      • Barry Davidson 4 months ago
        Reply

        would you rather be drunk on the wheel? Or high? Seems to me, both are a bad idea. We need products like the BCU in law enforcement possession to minimize abusers on the road

      • Wyatt Stovall 4 months ago
        Reply

        There is no other convenient way to test for THC in the system. Eventually, when federal legalization is accomplished, the demand for the BCU will be where it needs to be for law makers to take this product on a national scale

        • Tony Liu 3 months ago
          Reply

          I’m generally against drug testing for cannabis because it stays in system long after its effects wane. But many (most?) employers test employees, so yes, the president & members of Congress should be subject to random drug testing & a post-lunch alcohol breathalyzer. Adderall anyone?

      • Lisa Grey 3 months ago
        Reply

        Sometimes it’s nice to be in the stocks that the whole crowd isn’t in. I had wondered for some time when a Cannabis breathalyzer would eventually be used by law enforcement and employers.

  2. Tony Angelucci 4 months ago
    Reply

    when will the company finalize their marijuana breathalyzer system?

    • Fred Scott 3 months ago
      Reply

      things like this take time as there may be positive tests but the driver may be perfectly fine to drive

      • Tamara Mathias 3 months ago
        Reply

        another issue is who will be deciding the legal/illegal limits of being under the influence of cannabis. Will it be governments that rule over countries? My concern is that if lawmakers by individual states decide, then it will cause confusion

  3. Fred Katayama 3 months ago
    Reply

    what will occur if you refuse to take the cannabis breathalyzer test by law enforcement?

    • Emily Hayes 3 months ago
      Reply

      what is the count on drivers under the influence of cannabis behind the wheel

      • Daniel Borough 3 months ago
        Reply

        would like to see dual use of the breathalyzer to test for alcoholic content as well.

  4. Frank Blaze 3 months ago
    Reply

    How much marijuana in your system is too much to get behind the wheel? Riverside County Sheriff’s and a private company have teamed up to test a new breathalyzer that reads THC levels. Coachella Valley will be the testing ground.

    • Alexander Matthews 3 months ago
      Reply

      Many public health officials are questioning cannabis’ effect on public safety. A marijuana breathalyzer with reliable roadside testing would be game-changing in keeping roads safer.

      • Vanessa Louie 3 months ago
        Reply

        There are still many questions swirling around field sobriety tests for #cannabis. Regional police forces are trying to grapple with roadside cannabis intoxication without a federally approved breathalyzer-style test.

        • Ernest Edsel 4 weeks ago
          Reply

          Police are now taking roadside blood samples to catch impaired drivers. is their excuse that Breathalyzer no longer cut it because they made cannabis legal in some states?! #totalitarianism & a back door to your DNA.

    • Qing Lao 3 months ago
      Reply

      22 trillion national debt, and this is an issue? Declining and degraded infrastructure, rampant homelessness, social security insolvency. No offense, I don’t give a fuck about how many white dudes are cannabis ceo’s. Legalize weed nationally and move on to more important issues.

  5. Kyle Hasson 3 months ago
    Reply

    what if someone has years of cannabis use? Will that show on a breathalyzer test?

Leave a Comment

  • Sponsored Content Release

    FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

    Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For cannabix technologies inc. financial and corporate news dissemination, FinancialBuzz.com has been compensated seventeen thousand, five hundred dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com.